Sime Darby Plantation Bhd (5285)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 5.760 |
|---|---|
| 52-week range | 5.180 – 7.000 |
| Return, 1 month / 3 months | −7.7% / −12.6% |
| Return, 1 year / 3 years | +8.5% / +49.1% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 18.8% |
| Worst drawdown (1 year) | -18.4% |
| Average daily value traded | 70.60M MYR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sime Darby Plantation is a Malaysian agribusiness that cultivates oil palm and produces crude palm oil and palm kernel oil, along with downstream products such as refined oils and oleochemicals. It manages plantations and mills in Malaysia and other tropical countries, serving food, consumer goods and industrial customers around the world. The company is headquartered in Malaysia and also carries out research and development work on plantation crops and sustainable cultivation practices.
On this site Sime Darby Plantation Bhd appears as a stock on the Bursa Malaysia (Malaysia), code 5285, with prices in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sime Darby Plantation Bhd (5285) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 5.760 on 27 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 224 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.5% and over the last three months it fell 12.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.7% | ||
| From 52-week high | -16.6% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -12.6% | ||
| 6-month return | -2.9% | ||
| 12-month return, skipping the last month | 17.5% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.4% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 70.60M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | −7.7% |
| 3 months | −12.6% |
| 6 months | −2.9% |
| 1 year | +8.5% |
| 3 years | +49.1% |
| 5 years | +61.1% |
Signals
| 50-day / 200-day average | 6.168 / 6.047 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.140 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | MYR 0.1035 |
| 16 Oct 2025 | MYR 0.0775 |
| 8 May 2025 | MYR 0.1171 |
| 30 Oct 2024 | MYR 0.0465 |
| 3 May 2024 | MYR 0.0605 |
| 26 Dec 2023 | MYR 0.0570 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.